Clinical Trials
6 trialsNCT06765954 2026-05-05
Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
ImmunityBio, Inc.
Phase 2 Withdrawn
NCT06392841 2026-04-08
HARMONY
Hoosier Cancer Research Network
Phase 2 Withdrawn
NCT05567770 2023-08-24
ACTION
Weill Medical College of Cornell University
Phase 1 Withdrawn
NCT01811810 2019-04-23
Proton Therapy for High Risk Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Withdrawn
NCT00003517 2013-07-10
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00244920 2012-05-28
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
OHSU Knight Cancer Institute
Phase 2 Withdrawn